Pursuant to the correction that has taken place in recent weeks with respect to the shares in Arkema, further downside risk now appears limited by close and important technical support levels at 117.9 EUR.
Summary
● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
● According to Refinitiv, the company's ESG score for its industry is good.
Strengths
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
● Over the past four months, analysts' average price target has been revised upwards significantly.
● Consensus analysts have strongly revised their opinion of the company over the past 12 months.
● Historically, the company has been releasing figures that are above expectations.
Weaknesses
● The average consensus view of analysts covering the stock has deteriorated over the past four months.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
Arkema is one of the world's leaders in the development, manufacturing and marketing of chemical products. Net sales break down by family of products as follows:
- advanced materials (37.4%): high performance polymers, specialty surfactants, molecular sieves, organic peroxides, oxygenates, etc.;
- adhesives (28.5%): sealants, adhesives for floors and tiles, waterproofing products, etc.;
- coating solutions (25.3%): resins, emulsions for adhesives, surface coating products, absorbents, etc.;
- intermediate products (8.4%): thermoplastic polymers (PMMA), acrylic products, fluorinated gases, etc.;
- other (0.4%).
At the end of 2023, the group had 148 production sites worldwide.
Net sales are distributed geographically as follows: France (7.8%), Europe (26.6%), United States-Canada-Mexico (36.5%), China (11%), Asia (12.6%) and others (5.5% ).